Participant flow15

How many started, completed or left each group, period by period.

1 to 15 of 15

Period	Milestone	Group	Participants
Overall Study	STARTED	Febuxostat 80 mg QD	267
Overall Study	STARTED	Febuxostat 120 mg QD	269
Overall Study	STARTED	Febuxostat 240 mg QD	134
Overall Study	STARTED	Allopurinol QD	268
Overall Study	STARTED	Placebo QD	134
Overall Study	COMPLETED	Febuxostat 80 mg QD	174
Overall Study	COMPLETED	Febuxostat 120 mg QD	200
Overall Study	COMPLETED	Febuxostat 240 mg QD	86
Overall Study	COMPLETED	Allopurinol QD	211
Overall Study	COMPLETED	Placebo QD	101
Overall Study	NOT COMPLETED	Febuxostat 80 mg QD	93
Overall Study	NOT COMPLETED	Febuxostat 120 mg QD	69
Overall Study	NOT COMPLETED	Febuxostat 240 mg QD	48
Overall Study	NOT COMPLETED	Allopurinol QD	57
Overall Study	NOT COMPLETED	Placebo QD	33

Source ClinicalTrials.govtrials-2026-11-12-0.5.0

Sources 3

ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
ClinicalTrials.govNo license stated
NIH RePORTER's clinical studies and project filesPublic domain

Each source's terms

ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
ClinicalTrials.govnone stated
NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Twenty rows a page, as JSON. No key.

GET https://conductscience.org/api/trials/v1/NCT00174915/flow